As news of the highly anticipated COVID vaccine continues to provide hope during the pandemic, Pelican BioThermal is not wasting any time preparing its temperature-controlled solutions for when the vaccine does become available and is ready for distribution.

The global temperature-controlled packaging company released information this week on newly developed deep-frozen temperature packaging solutions ideal for transporting pharma-related products requiring temperature ranges of minus 80 degrees Celsius to minus 20 degrees Celsius.

“We know that pharmaceutical companies are in all phases of the development process for vaccines and therapeutics and working tirelessly to bring safe and effective drug products to market quickly,” said Greg Wheatley, Vice President of Worldwide New Product Development and Engineering at Pelican BioThermal. “Our engineering team matched this urgency to ensure they have the correct temperature-controlled packaging to meet them where they’re at in drug development for the pandemic recovery, from discovery to distribution.”

Prior to the development and launch of the company’s new offerings, its solutions portfolio included the Crēdo™ Cube. Not only is this specific offering reusable, but it offers ranges between minus 20 degree Celsius and minus 50 degree Celsius temperatures. The company cited advances in adaption and innovation for the competitive product line now offering temperature ranges including minus 20, minus 35, minus 50, and minus 80 degrees Celsius.

The temperature-expanded product line includes the Crēdo™ Cube, CoolGuard™ Advance, CoolPal™ Flex, Sherpa Systems™, Crēdo™ Xtreme and Crēdo™ Cargo shippers along with options through the Crēdo™ on Demand rental program. Options for both single-use and reusable temperature-controlled shippers are also available.